Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.

Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, Dilitz E, Deisenhammer F, Reindl M.

N Engl J Med. 2003 Jul 10;349(2):139-45.

2.

Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.

Rauer S, Euler B, Reindl M, Berger T.

J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):739-42.

3.

Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.

Kuhle J, Lindberg RL, Regeniter A, Mehling M, Hoffmann F, Reindl M, Berger T, Radue EW, Leppert D, Kappos L.

J Neurol. 2007 Feb;254(2):160-8.

PMID:
17334662
4.

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.

Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T.

Brain. 1999 Nov;122 ( Pt 11):2047-56.

PMID:
10545390
5.

Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.

Tomassini V, De Giglio L, Reindl M, Russo P, Pestalozza I, Pantano P, Berger T, Pozzilli C.

Mult Scler. 2007 Nov;13(9):1086-94. Epub 2007 Apr 27.

PMID:
17468447
6.

Lack of association between antimyelin antibodies and progression to multiple sclerosis.

Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R.

N Engl J Med. 2007 Jan 25;356(4):371-8.

7.

Antimyelin antibodies with no progression to multiple sclerosis.

Pelayo R, Tintoré M, Montalban X, Rovira A, Espejo C, Reindl M, Berger T.

N Engl J Med. 2007 Jan 25;356(4):426-8. No abstract available.

8.

Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis.

Schmidt S, Haase CG, Bezman L, Moser H, Schmidt M, Köhler W, Linington C, Klockgether T.

J Neuroimmunol. 2001 Sep 3;119(1):88-94.

PMID:
11525804
9.

Antimyelin antibodies in multiple sclerosis.

Mantegazza R.

N Engl J Med. 2003 Dec 4;349(23):2269-71; author reply 2269-71. No abstract available.

PMID:
14663868
12.

Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects.

Misikov VK, Kimova MV, Durova OM, Gabibov AG, Suchkov SV, Vorobev II, Ponomarenko NA.

Bull Exp Biol Med. 2005 Jan;139(1):85-8.

PMID:
16142285
13.

Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.

Mantegazza R, Cristaldini P, Bernasconi P, Baggi F, Pedotti R, Piccini I, Mascoli N, La Mantia L, Antozzi C, Simoncini O, Cornelio F, Milanese C.

Int Immunol. 2004 Apr;16(4):559-65.

PMID:
15039386
14.

Do myelin-directed antibodies predict multiple sclerosis?

Antel JP, Bar-Or A.

N Engl J Med. 2003 Jul 10;349(2):107-9. No abstract available.

PMID:
12853581
15.

Antimyelin antibodies in multiple sclerosis.

Chaudhuri A, Behan PO.

N Engl J Med. 2003 Dec 4;349(23):2269-71; author reply 2269-71. No abstract available.

PMID:
14663869
16.

Lack of association between antimyelin antibodies and progression to multiple sclerosis.

Berger T, Reindl M.

N Engl J Med. 2007 May 3;356(18):1888-9; author reply 1888-9. No abstract available.

17.

Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes.

Correale J, de los Milagros Bassani Molinas M.

J Neuroimmunol. 2003 Mar;136(1-2):162-71.

PMID:
12620656
18.

Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.

Olsson T, Baig S, Höjeberg B, Link H.

Ann Neurol. 1990 Feb;27(2):132-6.

PMID:
1690527
19.
20.

Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.

Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, Flechter S, Abramsky O, Milo R, Karni A, Ben-Nun A.

Eur J Immunol. 1997 Nov;27(11):3059-69.

PMID:
9394837

Supplemental Content

Support Center